Eli Lilly (LLY) Increases Yet Falls Behind Market: What Investors Need to Know

Eli Lilly closed at $1,164.89, up 1.04% but underperforming the S&P 500's 1.49% gain. The stock declined 8.16% over the past month, trailing the broader market. Analysts expect strong earnings growth of 36.18% YoY with revenue projected at $22.08 billion (+25.46%), but the company trades at a premium valuation with a Forward P/E of 31.94 versus the industry average of 15.87. Eli Lilly holds a Zacks Rank #3 (Hold) rating.